Gland Pharma Share Price

₹ 3,095.90

+₹21.40 (0.70%)
1D
Last updated 30 Oct, 2026, 15:54 IST
NSE: GLAND
|
Pharmaceuticals

Gland Pharma Share Price Today

As of 31 Oct 2026, Gland Pharma share price is ₹3,095.90. The stock opened at ₹3,070.00, compared to its previous close of ₹3,074.50. During today's trading session, Gland Pharma share price moved in the range of ₹3,051.00 to ₹3,114.20, with an average price of ₹3,082.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,573.60 and a high of ₹3,171.00. On the performance front, Gland Pharma share price has increased by 76.83% over the last six months and is up 62.45% on a year-on-year basis.

Share price over the last 1 day rose from 3087.00 to 3090.00, ranging between 3052.60 and 3113.40.
₹3,051.00
0.70% up today
₹3,114.20
1D LOW
1D HIGH

Gland Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 37.82% YoY
Latest Earning
Net Profit TrendUp by 47.07% YoY
Latest Earning
Revenue TrendUp by 0.39% QoQ
Stock Performance
OutperformingBeat Nifty by 1.87 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 11.62%
Shareholding Pattern
DIIDII increased stake by 67.11%
Shareholding Pattern
FIIFII increased stake by 18.55%
Gland Pharma stock performance
Open₹3,070.00
High₹3,114.20
Low₹3,051.00
Prev. close₹3,074.50
Gland Pharma trading activity
Volume3,00,302
Average traded price₹3,093.27
Last traded time03:54:20 30 Oct
Last traded quantity45
Circuit
L
H
₹2,459.60
₹3,689.40
52-week
L
H
₹1,573.60
₹3,171.00
Mkt Cap Cr
50,738.36
P/E
44.95
P/B
4.9
ROA
9.02%
ROE
9.92%
ROCE
14.02%
Quick Ratio
3.6
EV/EBITDA
23.08

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Gland Pharma outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Gland Pharma appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Gland Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,990.7634.915.0611.19%13.74%17.33%2.3121.39
Divis Laboratories2,56,309.9188.1715.3914.6%15.32%19.56%3.558.26
Torrent Pharmaceuticals1,73,461.0682.719.454.7%11.42%11.37%0.7533.22
Laurus Labs1,21,300.09111.2522.899.47%16.77%16.14%0.6857.63
Zydus Lifesciences1,18,303.9525.764.368.57%18.59%17.35%0.9115.57
Dr. Reddy's Laboratories1,11,463.2140.492.884.79%7.21%8.58%1.3518.82
Cipla1,09,628.0438.413.16.6%8.18%10.8%2.520.82
Mankind Pharma1,02,796.6044.915.787.82%12.76%14.68%0.7424.99
Aurobindo Pharma95,225.0425.662.516.34%9.25%11.76%1.1512.11
Lupin91,367.1416.464.0714.47%23.76%24.88%1.429.64

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Gland Pharma Company Background

ISIN
INE068V01023
Sector Market Cap
₹ 50,738.36 Cr

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.

Gland Pharma Financial Highlights

  • Revenue: Gland Pharma reported revenue of ₹6,746.98 crore in FY26 vs ₹5,830.11 crore in FY25. It showed an increase of 15.73% on a yearly basis.
  • Operating Profit: Gland Pharma reported an operating profit of ₹1,464.58 crore in FY26 vs ₹1,062.66 crore in FY25. It showed an increase of 37.82% on a year-on-year basis.
  • Net Profit: Gland Pharma reported a net profit of ₹1,027.32 crore in FY26 vs ₹698.53 crore in FY25. It showed an increase of 47.07% on a yearly basis.

Gland Pharma Quarterly Result Highlights

  • Gland Pharma reported revenue of ₹1,861.50 crore in Jun 2026, compared with ₹1,854.26 crore in Mar 2026, representing an increase of 0.39% on a quarter-on-quarter (QoQ) basis.
  • Gland Pharma reported an operating profit of ₹434.98 crore in Jun 2026, compared with ₹505.80 crore in Mar 2026, representing a decrease of 14.00% on a quarter-on-quarter (QoQ) basis.
  • Gland Pharma reported a profit of ₹316.96 crore in Jun 2026, compared with ₹366.68 crore in Mar 2026, reflecting a decrease of 13.56% on a QoQ basis.
  • The earnings per share (EPS) of Gland Pharma stood at ₹62.35 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
45.75%
FII
10.36%
Other DII
3.69%
Retail and other
10.67%
Mutual funds
29.52%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20257.58%
Mar 20267.30%
Jun 20268.74%
Sep 202610.36%

Gland Pharma Investment Returns

1 day
+0.70%
1 week
+9.52%
1 month
+6.78%
1 year
+62.45%
3 years
+101.79%
5 years
-16.33%

Gland Pharma Share Price History

Gland Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹3,070.00 / ₹3,095.90
+0.70%
29 Oct 26
₹3,060.00 / ₹3,074.50
+0.84%
28 Oct 26
₹2,950.00 / ₹3,049.00
+3.00%
27 Oct 26
₹2,858.90 / ₹2,960.30
+4.09%
Show more

Gland Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,430.65₹5,616.50₹5,664.72₹3,624.60
Other Income₹316.33₹213.61₹170.24₹240.46
Total Revenue₹6,746.98₹5,830.11₹5,834.96₹3,865.06
Total Expenses₹5,258.05₹4,767.45₹4,702.42₹2,754.02
Profit Before Tax₹1,464.58₹1,062.66₹1,132.54₹1,054.58
Tax₹437.26₹364.13₹360.08₹273.54
Profit After Tax₹1,027.32₹698.53₹772.46₹781.04
EPS - Basic₹62.35₹42.40₹46.90₹47.44
EPS - Diluted₹62.28₹42.40₹46.89₹47.43

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,464.58₹1,062.66₹1,132.54₹1,054.58
Income before WC changes₹1,741.34₹1,274.60₹1,356.15₹1,092.77
Change in Assets-₹176.26-₹141.92₹336.02-₹579.66
Change in Liabilities-₹78.23₹135.86-₹389.22₹161.72
Change in WC-₹254.50-₹6.06-₹53.20-₹417.94
Cash flow from Operations₹1,031.39₹914.73₹996.80₹363.97
Cash flow from Investing₹137.73₹1,704.74-₹1,756.91₹1,208.19
Cash flow from Financing-₹416.97-₹433.48-₹799.42₹14.92
Total Cash Flow₹752.14₹2,185.99-₹1,559.53₹1,587.08
Cash (Start of the year)₹2,556.21₹357.09₹1,908.90₹318.82
Cash (End of the year)₹3,359.11₹2,556.21₹357.09₹1,908.90

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,984.06₹4,441.98₹5,016.09₹1,876.73
Current Assets₹7,526.79₹6,782.94₹5,645.15₹6,900.81
Total Assets₹12,510.85₹11,224.92₹10,661.25₹8,777.54
Current Liabilities₹1,608.40₹1,564.85₹1,398.36₹729.13
Net Current Asset₹5,918.38₹5,218.09₹4,246.79₹6,171.68
Non-Current Liabilities₹544.50₹509.33₹539.04₹89.68
Equity Capital₹10,357.95₹9,150.74₹8,723.84₹7,958.72
Total Equity & Liabilities₹12,510.85₹11,224.92₹10,661.25₹8,777.54

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,552.09₹4,116.15₹4,167.43₹3,616.53
Other Income₹303.90₹215.08₹166.67₹240.46
Total Revenue₹4,855.99₹4,331.22₹4,334.09₹3,856.99
Total Expenses₹3,083.33₹2,865.64₹2,928.60₹2,752.13
Profit Before Tax₹1,748.31₹1,465.59₹1,405.50₹1,048.40
Tax₹448.76₹375.83₹362.17₹272.58
Profit After Tax₹1,299.55₹1,089.75₹1,043.33₹775.83
EPS - Basic₹78.88₹66.15₹63.35₹47.12
EPS - Diluted₹78.78₹66.15₹63.33₹47.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,748.31₹1,465.59₹1,405.50₹1,048.40
Income before WC changes₹1,767.49₹1,460.43₹1,428.65₹1,085.78
Change in Assets-₹301.39-₹121.33₹343.35-₹570.86
Change in Liabilities₹88.54₹86.74-₹319.97₹163.86
Change in WC-₹212.86-₹34.59₹23.38-₹407.00
Cash flow from Operations₹1,135.23₹1,073.67₹1,135.97₹367.89
Cash flow from Investing-₹95.56₹1,578.20-₹2,923.92₹1,208.22
Cash flow from Financing-₹316.18-₹339.54-₹7.40₹14.92
Total Cash Flow₹723.49₹2,312.33-₹1,795.35₹1,591.04
Cash (Start of the year)₹2,432.62₹116.21₹1,905.22₹311.18
Cash (End of the year)₹3,177.64₹2,432.62₹116.21₹1,905.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,185.00₹4,654.66₹4,969.76₹1,884.84
Current Assets₹6,422.22₹5,766.96₹4,571.33₹6,888.34
Total Assets₹11,607.21₹10,421.62₹9,541.09₹8,773.18
Current Liabilities₹633.03₹523.77₹414.20₹730.20
Net Current Asset₹5,789.19₹5,243.20₹4,157.13₹6,158.14
Non-Current Liabilities₹164.16₹142.75₹131.60₹89.68
Equity Capital₹10,810.03₹9,755.10₹8,995.29₹7,953.30
Total Equity & Liabilities₹11,607.21₹10,421.62₹9,541.09₹8,773.18
* All values are in INR Crore
Gland Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
13095.900
0000
0000
0000
0000
Total bid quantity1
Total ask quantity0
Gland Pharma technical summary
Bearish indicators5
Neutral indicators3
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
58.62
Neutral
ATR (14)
106.81
Neutral
STOCH(9,6)
89.25
Bearish
STOCH RSI (14)
87.33
Bearish
ADX(9)
27.92
Bearish
UO(9)
56.01
Neutral
ROC(12)
-0.13
Bearish
WillR(14)
-13.46
Bearish
Period
Simple value
Exponential vaue
5D
2950.9
2997.15
10D
2966.94
2981.86
20D
2993.71
2975.71
50D
2937.24
2897.29
100D
2702.48
2708.79
Volume trend — traded volume by day
30 Oct3L
29 Oct3L
28 Oct2L
27 Oct3L
26 Oct4L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Gland Pharma
Pharmaceuticals
Add Stock
Add Another

Gland Pharma Returns Calculator

Ex-date: 11 Aug 2026

Gland Pharma Latest News

1 month ago
Mankind, Dr Reddy, Gland Pharma, others lift Nifty Pharma up over 1% as US exempts certain drugs from 100% tariffs
1 month ago
HBL Engineering, Gland Pharma, MMTC shares surge amid spike in volumes; check full list
2 months ago
Naukri, Gland Pharma, Bosch among buzzing stocks as SENSEX falls over 400 pts, NIFTY trades below 24,500
2 months ago
Gland Pharma, CIE Automotive, MRPL shares surge amid spike in volumes; check full list
2 months ago
Gland Pharma shares jump 12% to 52-week high after strong Q1 show; are key growth challenges over?
2 months ago
Gland Pharma Q1 FY27 result: Net profit jumps 47% YoY; CDMO business contributed 50% of total revenues
5 months ago
Gland Pharma, NCC, Vi, Amber Enterprises among buzzing stocks as SENSEX, NIFTY50 trade flat
5 months ago
Gland Pharma share price hits 52-week high as Q4 profit nearly doubles, dividend announcement
Showing news item 1 of 8

Top Gainers

LAURUSLABS Share Price
₹2405.50
+161.5 (+7.2%)
TRENT Share Price
₹3017.30
+155.6 (+5.44%)
ZYDUSLIFE Share Price
₹1245.50
+61.1 (+5.16%)
NAVINFLUOR Share Price
₹8680.00
+419.5 (+5.08%)
POONAWALLA Share Price
₹461.70
+20.2 (+4.58%)
See more

Top Losers

INTELLECT Share Price
₹504.55
-98.3 (-16.31%)
REDINGTON Share Price
₹326.95
-30.2 (-8.46%)
SUZLON Share Price
₹33.90
-2.89 (-7.86%)
COHANCE Share Price
₹444.30
-37.05 (-7.7%)
PNCINFRA Share Price
₹123.93
-10.05 (-7.5%)
See more

Gland Pharma Share Price FAQs

Please be aware that Gland Pharma stock prices are subject to continuous fluctuations due to various factors.